Leuprorelin acetate Prescribing at WIGHT PRIMARY PARTNERSHIPS LTD
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
185
Total Quantity
185
NHS Cost
£38.4K
vs National Avg
+299.2%
WIGHT PRIMARY PARTNERSHIPS LTD prescribed 185 items of Leuprorelin acetate over the last 12 months at a cost of £38,445 to the NHS. This is 299.2% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
19
Jul 2026
10
Jul 2026
22
Jul 2026
14
Jul 2026
17
Jul 2026
18
Jul 2026
13
Jul 2026
11
Jul 2026
20
Jul 2026
11
Jul 2026
11
Jul 2026
19
Prescribing Details
| Total Items | 185 |
|---|---|
| Total Quantity | 185 |
| Total NHS Cost | £38,445 |
| Presentations | 2 different forms |
| vs National Average | +299.2% |
Leuprorelin acetate Prescribing Comparison
| This practice | 185 items |
|---|---|
| National average per practice | 46 items |
| Difference | +299.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.